Changes of proteins induced by anticoagulants can be more sensitively detected in urine than in plasma

Science China Life Sciences

Volumn 57, Issue 7, 2014, Pages 649-656

  Li, MengLin ^a   Zhao, MinDi ^a   Gao, YouHe ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

biomarker; homeostasis; plasma; proteomics; urine

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; BIOLOGICAL MARKER; HEPARIN; PIPECOLIC ACID DERIVATIVE; PROTEIN; PROTEOME;

ANIMAL; BLOOD; DRUG EFFECTS; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; LIQUID CHROMATOGRAPHY; PROCEDURES; PROTEOMICS; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY; URINE; WESTERN BLOTTING;

ANIMALS; ANTICOAGULANTS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; FEMALE; HEPARIN; INJECTIONS, INTRAVENOUS; PIPECOLIC ACIDS; PROTEINS; PROTEOME; PROTEOMICS; RATS, SPRAGUE-DAWLEY; TANDEM MASS SPECTROMETRY;

EID: 84904157623     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-014-4661-y     Document Type: Article

References (38)

1. Yi J, Kim C, Gelfand CA. Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma. J Proteome Res, 2007, 6: 1768-1781.
2. Decramer S, Gonzalez de Peredo A, Breuil B, Mischak H, Monsarrat B, Bascands JL, Schanstra JP. Urine in clinical proteomics. Mol Cell Proteomics, 2008, 7: 1850-1862.
3. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, Apweiler R, Haab BB, Simpson RJ, Eddes JS, Kapp EA, Moritz RL, Chan DW, Rai AJ, Admon A, Aebersold R, Eng J, Hancock WS, Hefta SA, Meyer H, Paik YK, Yoo JS, Ping P, Pounds J, Adkins J, Qian X, Wang R, Wasinger V, Wu CY, Zhao X, Zeng R, Archakov A, Tsugita A, Beer I, Pandey A, Pisano M, Andrews P, Tammen H, Speicher DW, Hanash SM. Overview of the hupo plasma proteome project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics, 2005, 5: 3226-3245.
4. Theodorescu D, Wittke S, Ross MM, Walden M, Conaway M, Just I, Mischak H, Frierson HF. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol, 2006, 7: 230-240.
5. Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nickerson P. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int, 2004, 65: 323-332.
6. Jia L, Liu X, Liu L, Li M, Gao Y. Urimem, a membrane that can store urinary proteins simply and economically, makes the large-scale storage of clinical samples possible. Peer J PrePrints, 2013, 1: e37v31.
7. Gao Y. Urine-an untapped goldmine for biomarker discovery? Sci China Life Sci, 2013, 56: 1145-1146.
8. Thongboonkerd V, McLeish KR, Arthur JM, Klein JB. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int, 2002, 62: 1461-1469.
9. Garcia-Manzano A, Gonzalez-Llaven J, Lemini C, Rubio-Poo C. Standardization of rat blood clotting tests with reagents used for humans. Proc West Pharmacol Soc, 2001, 44: 153-155.
10. Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods, 2009, 6: 359-362.
11. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem, 2002, 74: 5383-5392.
12. Hauck SM, Dietter J, Kramer RL, Hofmaier F, Zipplies JK, Amann B, Feuchtinger A, Deeg CA, Ueffing M. Deciphering membrane-associated molecular processes in target tissue of autoimmune uveitis by label-free quantitative mass spectrometry. Mol Cell Proteomics, 2010, 9: 2292-2305.
13. Brunzel N. Fundamentals of Urine & Body Fluid Analysis. Philadelphia: Saunders, 2004. 480.
14. Pieper R, Gatlin CL, Makusky AJ, Russo PS, Schatz CR, Miller SS, Su Q, McGrath AM, Estock MA, Parmar PP, Zhao M, Huang ST, Zhou J, Wang F, Esquer-Blasco R, Anderson NL, Taylor J, Steiner S. The human serum proteome: display of nearly 3700 chromatog-raphically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics, 2003, 3: 1345-1364.
15. Nagaraj N, Mann M. Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. J Proteome Res, 2011, 10: 637-645.
16. Adkins JN, Varnum SM, Auberry KJ, Moore RJ, Angell NH, Smith RD, Springer DL, Pounds JG. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics, 2002, 1: 947-955.
17. Mehta AI, Ross S, Lowenthal MS, Fusaro V, Fishman DA, Petricoin EF, 3rd, Liotta LA. Biomarker amplification by serum carrier protein binding. Dis Markers, 2003, 19: 1-10.
18. Shen Y, Kim J, Strittmatter EF, Jacobs JM, Camp DG, 2nd, Fang R, Tolie N, Moore RJ, Smith RD. Characterization of the human blood plasma proteome. Proteomics, 2005, 5: 4034-4045.
19. Kentsis A, Monigatti F, Dorff K, Campagne F, Bachur R, Steen H. Urine proteomics for profiling of human disease using high accuracy mass spectrometry. Proteomics Clin Appl, 2009, 3: 1052-1061.
20. Wang L, Li F, Sun W, Wu S, Wang X, Zhang L, Zheng D, Wang J, Gao Y. Concanavalin A-captured glycoproteins in healthy human urine. Mol Cell Proteomics, 2006, 5: 560-562.
21. Sleat DE, Zheng H, Lobel P. The human urine mannose 6-phosphate glycoproteome. Biochim Biophys Acta, 2007, 1774: 368-372.
22. Yang N, Feng S, Shedden K, Xie X, Liu Y, Rosser CJ, Lubman DM, Goodison S. Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification. Clin Cancer Res, 2011, 17: 3349-3359.
23. Halim A, Nilsson J, Rüetschi U, Hesse C, Larson G. Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD. Mol Cell Proteomics, 2012, 11: M111. 013649.
24. Khadjavi A, Barbero G, Destefanis P, Mandili G, Giribaldi G, Mannu F, Pantaleo A, Ceruti C, Bosio A, Rolle L, Turrini F, Fontana D. Evidence of abnormal tyrosine phosphorylated proteins in the urine of patients with bladder cancer: the road toward a new diagnostic tool? J Urol, 2011, 185: 1922-1929.
25. Liu L, Liu X, Sun W, Li M, Gao Y. Unrestrictive identification of post-translational modifications in the urine proteome without enrichment. Proteome science, 2013, 11: 1.
26. McDonald WH, Yates JR 3rd. Shotgun proteomics and biomarker discovery. Dis Markers, 2002, 18: 99-105.
27. Chen T, Xie G, Wang X, Fan J, Qiu Y, Zheng X, Qi X, Cao Y, Su M, Wang X, Xu LX, Yen Y, Liu P, Jia W. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics, 2011, 10: M110 004945.
28. Siwy J, Mullen W, Golovko I, Franke J, Zurbig P. Human urinary peptide database for multiple disease biomarker discovery. Proteomics Clin Appl, 2011, 5: 367-374.
29. Nicholson JK, Wilson ID. Understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov, 2003, 2: 668-676.
30. Shao C, Li M, Li X, Wei L, Zhu L, Yang F, Jia L, Mu Y, Wang J, Guo Z, Zhang D, Yin J, Wang Z, Sun W, Zhang Z, Gao Y. A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database. Mol Cell Proteomics, 2011, 10: M111 010975.
31. Wu T, Du Y, Han J, Singh S, Xie C, Guo Y, Zhou XJ, Ahn C, Saxena R, Mohan C. Urinary angiostatin-a novel putative marker of renal pathology chronicity in lupus nephritis. Mol Cell Proteomics, 2013, 12: 1170-1179.
32. Pories SE, Zurakowski D, Roy R, Lamb CC, Raza S, Exarhopoulos A, Scheib RG, Schumer S, Lenahan C, Borges V, Louis GW, Anand A, Isakovich N, Hirshfield-Bartek J, Wewer U, Lotz MM, Moses MA. Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment. Cancer Epidemiol Biomarkers Prev, 2008, 17: 1034-1042.
33. Huang JT, Chaudhuri R, Albarbarawi O, Barton A, Grierson C, Rauchhaus P, Weir CJ, Messow M, Stevens N, McSharry C, Feuerstein G, Mukhopadhyay S, Brady J, Palmer CN, Miller D, Thomson NC. Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease. Thorax, 2012, 67: 502-508.
34. Thomas CE, Sexton W, Benson K, Sutphen R, Koomen J. Urine collection and processing for protein biomarker discovery and quantification. Cancer Epidemiol Biomarkers Prev, 2010, 19: 953-959.
35. Weissinger EM, Wittke S, Kaiser T, Haller H, Bartel S, Krebs R, Golovko I, Rupprecht HD, Haubitz M, Hecker H, Mischak H, Fliser D. Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int, 2004, 65: 2426-2434.
36. Jantos-Siwy J, Schiffer E, Brand K, Schumann G, Rossing K, Delles C, Mischak H, Metzger J. Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. J Proteome Res, 2009, 8: 268-281.
37. Lankisch P, Wessalowski R, Maisonneuve P, Haghgu M, Hermsen D, Kramm CM. Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young age. Pediatr Blood Cancer, 2006, 46: 767-772.
38. Lemm G, Kuppers J, Frey R, Wingender W, Kuhlmann J. Monitoring of proteinuria in phase I studies in healthy male subjects. Eur J Clin Pharmacol, 1998, 54: 287-294.